ACE2 and cardiovascular disorder: The present study was conducted to provide a thorough evaluation of ACE2 levels and expression in human sera and tissue samples (heart and lung) in relation to risk factors for COVID-19 mortality, including cardiovascular diseases (hypertension, heart failure), advanced age, obesity and male sex [26].